These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22723693)

  • 1. Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models.
    Digby GJ; Noetzel MJ; Bubser M; Utley TJ; Walker AG; Byun NE; Lebois EP; Xiang Z; Sheffler DJ; Cho HP; Davis AA; Nemirovsky NE; Mennenga SE; Camp BW; Bimonte-Nelson HA; Bode J; Italiano K; Morrison R; Daniels JS; Niswender CM; Olive MF; Lindsley CW; Jones CK; Conn PJ
    J Neurosci; 2012 Jun; 32(25):8532-44. PubMed ID: 22723693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M
    Popiolek M; Nguyen DP; Reinhart V; Edgerton JR; Harms J; Lotarski SM; Steyn SJ; Davoren JE; Grimwood S
    Biochemistry; 2016 Dec; 55(51):7073-7085. PubMed ID: 27958713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode.
    Digby GJ; Utley TJ; Lamsal A; Sevel C; Sheffler DJ; Lebois EP; Bridges TM; Wood MR; Niswender CM; Lindsley CW; Conn PJ
    ACS Chem Neurosci; 2012 Dec; 3(12):1025-36. PubMed ID: 23259038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
    Shirey JK; Brady AE; Jones PJ; Davis AA; Bridges TM; Kennedy JP; Jadhav SB; Menon UN; Xiang Z; Watson ML; Christian EP; Doherty JJ; Quirk MC; Snyder DH; Lah JJ; Levey AI; Nicolle MM; Lindsley CW; Conn PJ
    J Neurosci; 2009 Nov; 29(45):14271-86. PubMed ID: 19906975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.
    Bradley SR; Lameh J; Ohrmund L; Son T; Bajpai A; Nguyen D; Friberg M; Burstein ES; Spalding TA; Ott TR; Schiffer HH; Tabatabaei A; McFarland K; Davis RE; Bonhaus DW
    Neuropharmacology; 2010 Feb; 58(2):365-73. PubMed ID: 19835892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
    Marlo JE; Niswender CM; Days EL; Bridges TM; Xiang Y; Rodriguez AL; Shirey JK; Brady AE; Nalywajko T; Luo Q; Austin CA; Williams MB; Kim K; Williams R; Orton D; Brown HA; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2009 Mar; 75(3):577-88. PubMed ID: 19047481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
    Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
    J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
    Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.
    Langmead CJ; Austin NE; Branch CL; Brown JT; Buchanan KA; Davies CH; Forbes IT; Fry VA; Hagan JJ; Herdon HJ; Jones GA; Jeggo R; Kew JN; Mazzali A; Melarange R; Patel N; Pardoe J; Randall AD; Roberts C; Roopun A; Starr KR; Teriakidis A; Wood MD; Whittington M; Wu Z; Watson J
    Br J Pharmacol; 2008 Jul; 154(5):1104-15. PubMed ID: 18454168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.
    Thorn CA; Moon J; Bourbonais CA; Harms J; Edgerton JR; Stark E; Steyn SJ; Butter CR; Lazzaro JT; O'Connor RE; Popiolek M
    ACS Chem Neurosci; 2019 Mar; 10(3):1753-1764. PubMed ID: 30480428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad analgesic activity of a novel, selective M1 agonist.
    Wood MW; Martino G; Coupal M; Lindberg M; Schroeder P; Santhakumar V; Valiquette M; Sandin J; Widzowski D; Laird J
    Neuropharmacology; 2017 Sep; 123():233-241. PubMed ID: 28623171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
    Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
    BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein coupling and signaling pathway activation by m1 muscarinic acetylcholine receptor orthosteric and allosteric agonists.
    Thomas RL; Mistry R; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2008 Nov; 327(2):365-74. PubMed ID: 18664591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
    Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
    Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-Modifying Effects of M
    Lebois EP; Schroeder JP; Esparza TJ; Bridges TM; Lindsley CW; Conn PJ; Brody DL; Daniels JS; Levey AI
    ACS Chem Neurosci; 2017 Jun; 8(6):1177-1187. PubMed ID: 28230352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bitopic Binding Mode of an M
    Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
    Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
    Thomas RL; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.